عن المجلة
Preclinical Studies is a peer-reviewed, open-access journal published by AIE_ GROUP since 2024, dedicated to advancing the understanding and application of preclinical research. The journal serves as a vital platform for researchers in biomedical and pharmaceutical sciences to disseminate innovative studies that bridge the gap between laboratory discoveries and clinical implementation.
Mission and Focus
The journal exclusively concentrates on high-quality preclinical research conducted in laboratory settings. This includes investigations using cell cultures and animal models to unravel disease mechanisms, explore novel therapeutic strategies, and assess the safety and efficacy of medical interventions prior to clinical trials. The mission of Preclinical Studies is to promote scientific rigor and innovation, supporting the translation of experimental findings into practical medical applications.
Key Features
- Open Access: Committed to the principle of unrestricted access, all articles are freely available online upon publication, fostering global knowledge sharing and collaboration.
- Publishing Frequency: Articles are published continuously and organized into two issues annually, released in January and July.
- Exclusive Scope: Focused solely on preclinical research, the journal prioritizes studies that contribute to understanding disease processes and developing therapeutic interventions.
Types of Articles
The journal welcomes a diverse range of contributions, including:
- Original Research Articles: Detailed studies presenting novel findings in preclinical research.
- Review Articles: Comprehensive analyses of current topics, providing insights into trends and challenges in the field.
- Method Development Studies: Innovative approaches and methodologies to enhance preclinical research practices.
Editorial Process
Preclinical Studies upholds the highest standards of scientific integrity through a rigorous, double-blind peer-review process. This ensures the publication of impactful and reliable research that advances the field.
Audience
The journal caters to a broad readership, including researchers, academics, and professionals in biomedical and pharmaceutical sciences, as well as policymakers and industry leaders interested in the preclinical development of medical innovations.
Commitment to Excellence
By fostering the dissemination of cutting-edge preclinical research, Preclinical Studies aims to support the global scientific community in overcoming challenges and paving the way for transformative medical breakthroughs.
